FTSE MIB
33.922,16 +40,66 (+0,12%) Dow Jones
37.986,99 +211,61 (+0,56%) Nasdaq
15.282,01 -319,49 (-2,05%) Nikkei 225
37.068,35 -1.011,35 (-2,66%) Petrolio
83,21 +0,48 (+0,58%) Bitcoin EUR
60.382,01 +756,20 (+1,27%)
Certara, Inc. (CERT)
Dopo ore:
| Chiusura precedente | 16,21 |
| Aperto | 16,24 |
| Denaro | 15,90 x 100 |
| Lettera | 15,95 x 100 |
| Min-Max giorno | 15,83 - 16,32 |
| Intervallo di 52 settimane | 11,81 - 24,96 |
| Volume | |
| Media Volume | 552.966 |
| Capitalizzazione | 2,552B |
| Beta (5 anni mensile) | 1,63 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -0,35 |
| Prossima data utili | 07 mag 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 19,72 |
GlobeNewswireCertara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference
PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2023 after the market close on Wednesday November 8th, 2023. Company management will host a conference call to discuss financial results at 5:00PM ET. Investors interested in listening to the conference call are required to register online. It is recommended to register at least one day in advance. Certar
- GlobeNewswire
Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software
Dedicated team of global regulatory experts delivers submissions in increasingly shorter timelinesPRINCETON, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced it has successfully supported 300 completed submissions to regulatory agencies worldwide. Submissions include those to initiate clinical trials, such as Investigational New Drug (IND) or Clinical Trial Application (CTA) and marketing applications, such as New Drug Appli
- GlobeNewswire
Certara to Participate in Upcoming Investor Conferences
PRINCETON, N.J., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the following investor conferences: Morgan Stanley 21st Annual Global Healthcare Conference Date and Time: Tuesday, September 12 at 5:30 p.m. ET Baird Global Healthcare Conference Date and Time: Wednesday, September 13 at 3:45 p.m. ET Live webcasts for each of the conferences will be available on Certara’s investor relation
